Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules.
Saved in:
| Title: | Bioequivalence, safety, and tolerability of imatinib tablets compared with capsules. |
|---|---|
| Authors: | Nikolova Z; Novartis Oncology, Basel, Switzerland. zariana.nikolova@pharma.novartis.com, Peng B, Hubert M, Sieberling M, Keller U, Ho YY, Schran H, Capdeville R |
| Source: | Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2004 May; Vol. 53 (5), pp. 433-8. |
| Publication Type: | Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print Cited Medium: Print ISSN: 0344-5704 (Print) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
